ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lung Cancer Diagnostic And Screening Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-3L15716
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Lung Cancer Diagnostic And Screening Market Research Report 2023
BUY CHAPTERS

Global Lung Cancer Diagnostic And Screening Market Research Report 2025

Code: QYRE-Auto-3L15716
Report
May 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
F. Hoffmann-La Roche AG
Bristol Myers Squibb Company
Thermo Fisher Scientific
Astrazeneca plc
Abbott Laboratories
Medtronic Inc
Danaher Corporation
Siemens Healthcare GmbH
Fujifilm Corporation
Qiagen NV
NeoGenomics Laboratories Inc.
KoninklijikePhilips N.V.
GE Healthcare Bio Sciences AB
Quest Diagnostics lIncorporated
Agilent Technologies lnc
Myriad Genetic Laboratories Inc.
Canon MedicalSystems Corporation
Eon Health Inc

Lung Cancer Diagnostic And Screening Market Size

The global market for Lung Cancer Diagnostic And Screening was valued at US$ 83.6 million in the year 2024 and is projected to reach a revised size of US$ 114 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Lung Cancer Diagnostic And Screening Market

Lung Cancer Diagnostic And Screening Market

The Lung Cancer Diagnostic and Screening market is experiencing significant growth and is expected to continue to expand in the coming years. Lung cancer is a major global health concern, and early detection and accurate diagnosis are crucial for improving patient outcomes.One major trend in the Lung Cancer Diagnostic and Screening market is the increasing adoption of advanced imaging technologies for lung cancer detection. Technologies such as computed tomography (CT) scans and positron emission tomography (PET) scans are widely used for screening and diagnosing lung cancer. These imaging techniques provide detailed images of the lungs, allowing healthcare professionals to detect lung nodules or tumors at an early stage.
This report aims to provide a comprehensive presentation of the global market for Lung Cancer Diagnostic And Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Diagnostic And Screening.
The Lung Cancer Diagnostic And Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Cancer Diagnostic And Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Cancer Diagnostic And Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Lung Cancer Diagnostic And Screening Market Report

Report Metric Details
Report Name Lung Cancer Diagnostic And Screening Market
Accounted market size in year US$ 83.6 million
Forecasted market size in 2031 US$ 114 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, F.Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, AstraZeneca Plc, Abbott Laboratories, Medtronic Plc, Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, KoninklijikePhilips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics lIncorporated, Agilent Technologies lnc, Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc, Canon MedicalSystems Corporation, Eon Health Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Lung Cancer Diagnostic And Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lung Cancer Diagnostic And Screening Market growing?

Ans: The Lung Cancer Diagnostic And Screening Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Lung Cancer Diagnostic And Screening Market size in 2031?

Ans: The Lung Cancer Diagnostic And Screening Market size in 2031 will be US$ 114 million.

Who are the main players in the Lung Cancer Diagnostic And Screening Market report?

Ans: The main players in the Lung Cancer Diagnostic And Screening Market are Pfizer, F.Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, AstraZeneca Plc, Abbott Laboratories, Medtronic Plc, Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, KoninklijikePhilips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics lIncorporated, Agilent Technologies lnc, Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc, Canon MedicalSystems Corporation, Eon Health Inc

What are the Application segmentation covered in the Lung Cancer Diagnostic And Screening Market report?

Ans: The Applications covered in the Lung Cancer Diagnostic And Screening Market report are Hospital, Independent Diagnostic Laboratory

What are the Type segmentation covered in the Lung Cancer Diagnostic And Screening Market report?

Ans: The Types covered in the Lung Cancer Diagnostic And Screening Market report are Instrument, Consumables and Accessories

Recommended Reports

Lung Cancer Diagnostics

Cancer Diagnostics Market

Screening & Imaging Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instrument
1.2.3 Consumables and Accessories
1.3 Market by Application
1.3.1 Global Lung Cancer Diagnostic And Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Independent Diagnostic Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Diagnostic And Screening Market Perspective (2020-2031)
2.2 Global Lung Cancer Diagnostic And Screening Growth Trends by Region
2.2.1 Global Lung Cancer Diagnostic And Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lung Cancer Diagnostic And Screening Historic Market Size by Region (2020-2025)
2.2.3 Lung Cancer Diagnostic And Screening Forecasted Market Size by Region (2026-2031)
2.3 Lung Cancer Diagnostic And Screening Market Dynamics
2.3.1 Lung Cancer Diagnostic And Screening Industry Trends
2.3.2 Lung Cancer Diagnostic And Screening Market Drivers
2.3.3 Lung Cancer Diagnostic And Screening Market Challenges
2.3.4 Lung Cancer Diagnostic And Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Diagnostic And Screening Players by Revenue
3.1.1 Global Top Lung Cancer Diagnostic And Screening Players by Revenue (2020-2025)
3.1.2 Global Lung Cancer Diagnostic And Screening Revenue Market Share by Players (2020-2025)
3.2 Global Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lung Cancer Diagnostic And Screening Revenue
3.4 Global Lung Cancer Diagnostic And Screening Market Concentration Ratio
3.4.1 Global Lung Cancer Diagnostic And Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostic And Screening Revenue in 2024
3.5 Global Key Players of Lung Cancer Diagnostic And Screening Head office and Area Served
3.6 Global Key Players of Lung Cancer Diagnostic And Screening, Product and Application
3.7 Global Key Players of Lung Cancer Diagnostic And Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Diagnostic And Screening Breakdown Data by Type
4.1 Global Lung Cancer Diagnostic And Screening Historic Market Size by Type (2020-2025)
4.2 Global Lung Cancer Diagnostic And Screening Forecasted Market Size by Type (2026-2031)
5 Lung Cancer Diagnostic And Screening Breakdown Data by Application
5.1 Global Lung Cancer Diagnostic And Screening Historic Market Size by Application (2020-2025)
5.2 Global Lung Cancer Diagnostic And Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lung Cancer Diagnostic And Screening Market Size (2020-2031)
6.2 North America Lung Cancer Diagnostic And Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025)
6.4 North America Lung Cancer Diagnostic And Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Cancer Diagnostic And Screening Market Size (2020-2031)
7.2 Europe Lung Cancer Diagnostic And Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025)
7.4 Europe Lung Cancer Diagnostic And Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size (2020-2031)
8.2 Asia-Pacific Lung Cancer Diagnostic And Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Cancer Diagnostic And Screening Market Size (2020-2031)
9.2 Latin America Lung Cancer Diagnostic And Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025)
9.4 Latin America Lung Cancer Diagnostic And Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size (2020-2031)
10.2 Middle East & Africa Lung Cancer Diagnostic And Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Lung Cancer Diagnostic And Screening Introduction
11.1.4 Pfizer Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 F.Hoffmann-La Roche AG
11.2.1 F.Hoffmann-La Roche AG Company Details
11.2.2 F.Hoffmann-La Roche AG Business Overview
11.2.3 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Introduction
11.2.4 F.Hoffmann-La Roche AG Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.2.5 F.Hoffmann-La Roche AG Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Introduction
11.4.4 Thermo Fisher Scientific Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 AstraZeneca Plc
11.5.1 AstraZeneca Plc Company Details
11.5.2 AstraZeneca Plc Business Overview
11.5.3 AstraZeneca Plc Lung Cancer Diagnostic And Screening Introduction
11.5.4 AstraZeneca Plc Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.5.5 AstraZeneca Plc Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Lung Cancer Diagnostic And Screening Introduction
11.6.4 Abbott Laboratories Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.6.5 Abbott Laboratories Recent Development
11.7 Medtronic Plc
11.7.1 Medtronic Plc Company Details
11.7.2 Medtronic Plc Business Overview
11.7.3 Medtronic Plc Lung Cancer Diagnostic And Screening Introduction
11.7.4 Medtronic Plc Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.7.5 Medtronic Plc Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Lung Cancer Diagnostic And Screening Introduction
11.8.4 Danaher Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Siemens Healthcare GmbH
11.9.1 Siemens Healthcare GmbH Company Details
11.9.2 Siemens Healthcare GmbH Business Overview
11.9.3 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Introduction
11.9.4 Siemens Healthcare GmbH Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.9.5 Siemens Healthcare GmbH Recent Development
11.10 FUJIFILM Corporation
11.10.1 FUJIFILM Corporation Company Details
11.10.2 FUJIFILM Corporation Business Overview
11.10.3 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Introduction
11.10.4 FUJIFILM Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.10.5 FUJIFILM Corporation Recent Development
11.11 KoninklijikePhilips N.V.
11.11.1 KoninklijikePhilips N.V. Company Details
11.11.2 KoninklijikePhilips N.V. Business Overview
11.11.3 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Introduction
11.11.4 KoninklijikePhilips N.V. Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.11.5 KoninklijikePhilips N.V. Recent Development
11.12 GE Healthcare Bio Sciences AB
11.12.1 GE Healthcare Bio Sciences AB Company Details
11.12.2 GE Healthcare Bio Sciences AB Business Overview
11.12.3 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Introduction
11.12.4 GE Healthcare Bio Sciences AB Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.12.5 GE Healthcare Bio Sciences AB Recent Development
11.13 Quest Diagnostics lIncorporated
11.13.1 Quest Diagnostics lIncorporated Company Details
11.13.2 Quest Diagnostics lIncorporated Business Overview
11.13.3 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Introduction
11.13.4 Quest Diagnostics lIncorporated Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.13.5 Quest Diagnostics lIncorporated Recent Development
11.14 Agilent Technologies lnc
11.14.1 Agilent Technologies lnc Company Details
11.14.2 Agilent Technologies lnc Business Overview
11.14.3 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Introduction
11.14.4 Agilent Technologies lnc Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.14.5 Agilent Technologies lnc Recent Development
11.15 Qiagen Inc.
11.15.1 Qiagen Inc. Company Details
11.15.2 Qiagen Inc. Business Overview
11.15.3 Qiagen Inc. Lung Cancer Diagnostic And Screening Introduction
11.15.4 Qiagen Inc. Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.15.5 Qiagen Inc. Recent Development
11.16 Myriad Genetic Laboratories Inc.
11.16.1 Myriad Genetic Laboratories Inc. Company Details
11.16.2 Myriad Genetic Laboratories Inc. Business Overview
11.16.3 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Introduction
11.16.4 Myriad Genetic Laboratories Inc. Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.16.5 Myriad Genetic Laboratories Inc. Recent Development
11.17 NeoGenomics Laboratories Inc
11.17.1 NeoGenomics Laboratories Inc Company Details
11.17.2 NeoGenomics Laboratories Inc Business Overview
11.17.3 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Introduction
11.17.4 NeoGenomics Laboratories Inc Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.17.5 NeoGenomics Laboratories Inc Recent Development
11.18 Canon MedicalSystems Corporation
11.18.1 Canon MedicalSystems Corporation Company Details
11.18.2 Canon MedicalSystems Corporation Business Overview
11.18.3 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Introduction
11.18.4 Canon MedicalSystems Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.18.5 Canon MedicalSystems Corporation Recent Development
11.19 Eon Health Inc
11.19.1 Eon Health Inc Company Details
11.19.2 Eon Health Inc Business Overview
11.19.3 Eon Health Inc Lung Cancer Diagnostic And Screening Introduction
11.19.4 Eon Health Inc Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025)
11.19.5 Eon Health Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
F. Hoffmann-La Roche AG
Bristol Myers Squibb Company
Thermo Fisher Scientific
Astrazeneca plc
Abbott Laboratories
Medtronic Inc
Danaher Corporation
Siemens Healthcare GmbH
Fujifilm Corporation
Qiagen NV
NeoGenomics Laboratories Inc.
KoninklijikePhilips N.V.
GE Healthcare Bio Sciences AB
Quest Diagnostics lIncorporated
Agilent Technologies lnc
Myriad Genetic Laboratories Inc.
Canon MedicalSystems Corporation
Eon Health Inc
List of Tables
 Table 1. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Instrument
 Table 3. Key Players of Consumables and Accessories
 Table 4. Global Lung Cancer Diagnostic And Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Lung Cancer Diagnostic And Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Lung Cancer Diagnostic And Screening Market Share by Region (2020-2025)
 Table 8. Global Lung Cancer Diagnostic And Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Lung Cancer Diagnostic And Screening Market Share by Region (2026-2031)
 Table 10. Lung Cancer Diagnostic And Screening Market Trends
 Table 11. Lung Cancer Diagnostic And Screening Market Drivers
 Table 12. Lung Cancer Diagnostic And Screening Market Challenges
 Table 13. Lung Cancer Diagnostic And Screening Market Restraints
 Table 14. Global Lung Cancer Diagnostic And Screening Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Lung Cancer Diagnostic And Screening Market Share by Players (2020-2025)
 Table 16. Global Top Lung Cancer Diagnostic And Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic And Screening as of 2024)
 Table 17. Ranking of Global Top Lung Cancer Diagnostic And Screening Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Lung Cancer Diagnostic And Screening Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Lung Cancer Diagnostic And Screening, Headquarters and Area Served
 Table 20. Global Key Players of Lung Cancer Diagnostic And Screening, Product and Application
 Table 21. Global Key Players of Lung Cancer Diagnostic And Screening, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Lung Cancer Diagnostic And Screening Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Lung Cancer Diagnostic And Screening Revenue Market Share by Type (2020-2025)
 Table 25. Global Lung Cancer Diagnostic And Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Lung Cancer Diagnostic And Screening Revenue Market Share by Type (2026-2031)
 Table 27. Global Lung Cancer Diagnostic And Screening Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Lung Cancer Diagnostic And Screening Revenue Market Share by Application (2020-2025)
 Table 29. Global Lung Cancer Diagnostic And Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Lung Cancer Diagnostic And Screening Revenue Market Share by Application (2026-2031)
 Table 31. North America Lung Cancer Diagnostic And Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Lung Cancer Diagnostic And Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Lung Cancer Diagnostic And Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Lung Cancer Diagnostic And Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lung Cancer Diagnostic And Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Lung Cancer Diagnostic And Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Pfizer Company Details
 Table 47. Pfizer Business Overview
 Table 48. Pfizer Lung Cancer Diagnostic And Screening Product
 Table 49. Pfizer Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 50. Pfizer Recent Development
 Table 51. F.Hoffmann-La Roche AG Company Details
 Table 52. F.Hoffmann-La Roche AG Business Overview
 Table 53. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product
 Table 54. F.Hoffmann-La Roche AG Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 55. F.Hoffmann-La Roche AG Recent Development
 Table 56. Bristol-Myers Squibb Company Company Details
 Table 57. Bristol-Myers Squibb Company Business Overview
 Table 58. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product
 Table 59. Bristol-Myers Squibb Company Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 60. Bristol-Myers Squibb Company Recent Development
 Table 61. Thermo Fisher Scientific Company Details
 Table 62. Thermo Fisher Scientific Business Overview
 Table 63. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product
 Table 64. Thermo Fisher Scientific Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 65. Thermo Fisher Scientific Recent Development
 Table 66. AstraZeneca Plc Company Details
 Table 67. AstraZeneca Plc Business Overview
 Table 68. AstraZeneca Plc Lung Cancer Diagnostic And Screening Product
 Table 69. AstraZeneca Plc Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 70. AstraZeneca Plc Recent Development
 Table 71. Abbott Laboratories Company Details
 Table 72. Abbott Laboratories Business Overview
 Table 73. Abbott Laboratories Lung Cancer Diagnostic And Screening Product
 Table 74. Abbott Laboratories Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 75. Abbott Laboratories Recent Development
 Table 76. Medtronic Plc Company Details
 Table 77. Medtronic Plc Business Overview
 Table 78. Medtronic Plc Lung Cancer Diagnostic And Screening Product
 Table 79. Medtronic Plc Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 80. Medtronic Plc Recent Development
 Table 81. Danaher Corporation Company Details
 Table 82. Danaher Corporation Business Overview
 Table 83. Danaher Corporation Lung Cancer Diagnostic And Screening Product
 Table 84. Danaher Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 85. Danaher Corporation Recent Development
 Table 86. Siemens Healthcare GmbH Company Details
 Table 87. Siemens Healthcare GmbH Business Overview
 Table 88. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product
 Table 89. Siemens Healthcare GmbH Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 90. Siemens Healthcare GmbH Recent Development
 Table 91. FUJIFILM Corporation Company Details
 Table 92. FUJIFILM Corporation Business Overview
 Table 93. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product
 Table 94. FUJIFILM Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 95. FUJIFILM Corporation Recent Development
 Table 96. KoninklijikePhilips N.V. Company Details
 Table 97. KoninklijikePhilips N.V. Business Overview
 Table 98. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product
 Table 99. KoninklijikePhilips N.V. Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 100. KoninklijikePhilips N.V. Recent Development
 Table 101. GE Healthcare Bio Sciences AB Company Details
 Table 102. GE Healthcare Bio Sciences AB Business Overview
 Table 103. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product
 Table 104. GE Healthcare Bio Sciences AB Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 105. GE Healthcare Bio Sciences AB Recent Development
 Table 106. Quest Diagnostics lIncorporated Company Details
 Table 107. Quest Diagnostics lIncorporated Business Overview
 Table 108. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product
 Table 109. Quest Diagnostics lIncorporated Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 110. Quest Diagnostics lIncorporated Recent Development
 Table 111. Agilent Technologies lnc Company Details
 Table 112. Agilent Technologies lnc Business Overview
 Table 113. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product
 Table 114. Agilent Technologies lnc Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 115. Agilent Technologies lnc Recent Development
 Table 116. Qiagen Inc. Company Details
 Table 117. Qiagen Inc. Business Overview
 Table 118. Qiagen Inc. Lung Cancer Diagnostic And Screening Product
 Table 119. Qiagen Inc. Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 120. Qiagen Inc. Recent Development
 Table 121. Myriad Genetic Laboratories Inc. Company Details
 Table 122. Myriad Genetic Laboratories Inc. Business Overview
 Table 123. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product
 Table 124. Myriad Genetic Laboratories Inc. Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 125. Myriad Genetic Laboratories Inc. Recent Development
 Table 126. NeoGenomics Laboratories Inc Company Details
 Table 127. NeoGenomics Laboratories Inc Business Overview
 Table 128. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product
 Table 129. NeoGenomics Laboratories Inc Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 130. NeoGenomics Laboratories Inc Recent Development
 Table 131. Canon MedicalSystems Corporation Company Details
 Table 132. Canon MedicalSystems Corporation Business Overview
 Table 133. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product
 Table 134. Canon MedicalSystems Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 135. Canon MedicalSystems Corporation Recent Development
 Table 136. Eon Health Inc Company Details
 Table 137. Eon Health Inc Business Overview
 Table 138. Eon Health Inc Lung Cancer Diagnostic And Screening Product
 Table 139. Eon Health Inc Revenue in Lung Cancer Diagnostic And Screening Business (2020-2025) & (US$ Million)
 Table 140. Eon Health Inc Recent Development
 Table 141. Research Programs/Design for This Report
 Table 142. Key Data Information from Secondary Sources
 Table 143. Key Data Information from Primary Sources
 Table 144. Authors List of This Report


List of Figures
 Figure 1. Lung Cancer Diagnostic And Screening Picture
 Figure 2. Global Lung Cancer Diagnostic And Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lung Cancer Diagnostic And Screening Market Share by Type: 2024 VS 2031
 Figure 4. Instrument Features
 Figure 5. Consumables and Accessories Features
 Figure 6. Global Lung Cancer Diagnostic And Screening Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Lung Cancer Diagnostic And Screening Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Independent Diagnostic Laboratory Case Studies
 Figure 10. Lung Cancer Diagnostic And Screening Report Years Considered
 Figure 11. Global Lung Cancer Diagnostic And Screening Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Lung Cancer Diagnostic And Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Lung Cancer Diagnostic And Screening Market Share by Region: 2024 VS 2031
 Figure 14. Global Lung Cancer Diagnostic And Screening Market Share by Players in 2024
 Figure 15. Global Top Lung Cancer Diagnostic And Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic And Screening as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Lung Cancer Diagnostic And Screening Revenue in 2024
 Figure 17. North America Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Lung Cancer Diagnostic And Screening Market Share by Country (2020-2031)
 Figure 19. United States Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Lung Cancer Diagnostic And Screening Market Share by Country (2020-2031)
 Figure 23. Germany Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Lung Cancer Diagnostic And Screening Market Share by Region (2020-2031)
 Figure 31. China Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Lung Cancer Diagnostic And Screening Market Share by Country (2020-2031)
 Figure 39. Mexico Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Lung Cancer Diagnostic And Screening Market Share by Country (2020-2031)
 Figure 43. Turkey Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Lung Cancer Diagnostic And Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Pfizer Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 47. F.Hoffmann-La Roche AG Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 50. AstraZeneca Plc Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 51. Abbott Laboratories Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 52. Medtronic Plc Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 53. Danaher Corporation Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 54. Siemens Healthcare GmbH Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 55. FUJIFILM Corporation Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 56. KoninklijikePhilips N.V. Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 57. GE Healthcare Bio Sciences AB Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 58. Quest Diagnostics lIncorporated Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 59. Agilent Technologies lnc Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 60. Qiagen Inc. Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 61. Myriad Genetic Laboratories Inc. Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 62. NeoGenomics Laboratories Inc Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 63. Canon MedicalSystems Corporation Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 64. Eon Health Inc Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Lung Cancer Screening Software Market Research Report 2024
Global Lung Cancer Diagnostics Kit Market Research Report 2024
Global Lung Cancer Molecular Diagnostics Market Research Report 2024
Global Lung Cancer Diagnostic Tests Market Research Report 2024
Global Cancer Screening Technology Market Research Report 2024
Global Lung Cancer Test Kit Market Research Report 2024
Global Lung CT Image assisted Detection Software Market Research Report 2024
Global Tumor Marker Testing Market Research Report 2024
Global Lung Cancer Genomic Testing Market Research Report 2024
Global Emerging Cancer Diagnostics Market Research Report 2024
Global Breast Cancer Diagnostic and Drug Technologies Market Insights Forecast to 2030
Global Urothelial Carcinoma Diagnostics Market Research Report 2024
Global Cancer Imaging System Market Research Report 2025
Global Mobile Cancer Screening Devices Market Insights Forecast to 2030
Global Diagnostic Imaging Devices Market Research Report 2024
Global Portable Cancer Screening Devices Market Research Report 2024
Cancer Early Detection and Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lung CT Market Research Report 2024
Colorectal Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Portable Computerized Tomography Scanners Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions